Days Speakers Session Type Search
Type

    08:00 - 16:00 
    Registration
    City Hall Main Entrance
    08:15 - 09:15 
    Sponsored Symposium
    09:30 - 11:00 
    Symposium 3
    Diabetes Trials
    ASSEMBLY ROOM
    Chair: Rachel Besser (Oxford)
    S3.1
    Symposium 3
    Immunotherapy in Type 1 diabetes
    Cardiff, Wales
    S3.2
    Symposium 3
    Role of the environment in the pathogenesis of Type 1 diabetes
    S3.3
    Symposium 3
    Novel therapies for type 2 diabetes
    11:00 - 11:30 
    TEA & COFFEE
    LOWER HALL
    11:30 - 13:00 
    Oral Communications 7
    ASSEMBLY ROOM
    Chairs: Eleri Williams (Winchester) & Fiona Regan (Wrexham)
    OC7.1
    Oral Communications 7
    Increased and younger alcohol-related hospital admissions in young people with childhood-onset type-1 diabetes: a record-linked longitudinal population study in Wales
    UK
    OC7.2
    Oral Communications 7
    Impact of Continuous Glucose Monitoring on Sleep Quality in Children with Type 1 Diabetes and their Parents: A Pilot Study
    OC7.3
    Oral Communications 7
    Improving HbA1c Outcomes in Young People of Transition Age with Type 1 Diabetes Using Quality Improvement Methodology
    OC7.4
    Oral Communications 7
    Monitoring lipid profiles in children and young people with Type 1 Diabetes Mellitus: What should we do with these results?
    Liverpool, UK
    OC7.5
    Oral Communications 7
    Medication adherence during adjunct therapy with statins and ACE inhibitors in adolescents with type 1 diabetes
    OC7.6
    Oral Communications 7
    Improving referral pathways from primary to secondary care in newly diagnosed Type 1 diabetes
    OC7.7
    Oral Communications 7
    Paediatric Type 2 diabetes in a single centre in East London in the period 2009-2018
    London, UK
    OC7.8
    Oral Communications 7
    Children with type 1 diabetes on intensive insulin, in deprived areas and younger onset are at risk of being overweight.
    OC7.9
    Oral Communications 7
    Does having a first degree relative with Type1 Diabetes impact on a child and family’s engagement and glycaemic control?
    13:00 - 14:00 
    LUNCH, EXHIBITION & POSTER TOURS
    LOWER HALL
    14:00 - 14:15 
    BSPED 2019 AWARDS SESSION
    ASSEMBLY ROOM
    Chair: Helen Storr (London)
    14:15 - 15:45 
    Symposium 4
    Improving Diabetes Care
    ASSEMBLY ROOM
    Chair: Fiona Campbell (Leeds)
    S4.1
    Symposium 4
    How to use QI effectively
    S4.2
    Symposium 4
    QI in action - the Sheffield Children's Hospital experience
    S4.3
    Symposium 4
    Lessons from registries
    UK
    15:45 - 16:00 
    Close of Meeting
    ASSEMBLY ROOM
    Chair: Justin Warner (Cardiff)
Tricia	Woodhead
Fri 29 14:15
S4.1
Symposium 4
How to use QI effectively
Carrie	Mackenzie
Fri 29 14:45
S4.2
Symposium 4
QI in action - the Sheffield Children's Hospital experience
Tim Barrett
Fri 29 10:30
S3.3
Symposium 3
Novel therapies for type 2 diabetes
Colin Dayan
Cardiff, Wales
Fri 29 09:30
S3.1
Symposium 3
Immunotherapy in Type 1 diabetes
Cardiff, Wales
Emma Dymond
Fri 29 11:50
OC7.3
Oral Communications 7
Improving HbA1c Outcomes in Young People of Transition Age with Type 1 Diabetes Using Quality Improvement Methodology
Evelien Gevers
London, UK
Fri 29 12:30
OC7.7
Oral Communications 7
Paediatric Type 2 diabetes in a single centre in East London in the period 2009-2018
London, UK
John Gregory
UK
Fri 29 11:30
OC7.1
Oral Communications 7
Increased and younger alcohol-related hospital admissions in young people with childhood-onset type-1 diabetes: a record-linked longitudinal population study in Wales
UK
John Gregory
UK
Fri 29 15:15
S4.3
Symposium 4
Lessons from registries
UK
Evelyne Kiu
Fri 29 12:50
OC7.9
Oral Communications 7
Does having a first degree relative with Type1 Diabetes impact on a child and family’s engagement and glycaemic control?
M. Marcovecchio
Fri 29 12:10
OC7.5
Oral Communications 7
Medication adherence during adjunct therapy with statins and ACE inhibitors in adolescents with type 1 diabetes
Julie Park
Liverpool, UK
Fri 29 12:00
OC7.4
Oral Communications 7
Monitoring lipid profiles in children and young people with Type 1 Diabetes Mellitus: What should we do with these results?
Liverpool, UK
Ambika Shetty
Fri 29 12:20
OC7.6
Oral Communications 7
Improving referral pathways from primary to secondary care in newly diagnosed Type 1 diabetes
Alexandra Urquhart
Fri 29 12:40
OC7.8
Oral Communications 7
Children with type 1 diabetes on intensive insulin, in deprived areas and younger onset are at risk of being overweight.
F. Wong
Fri 29 10:00
S3.2
Symposium 3
Role of the environment in the pathogenesis of Type 1 diabetes
Workshop 0
Oral 1
Fri 29 11:30
Oral Communications 7
ASSEMBLY ROOM
Chairs: Eleri Williams (Winchester) & Fiona Regan (Wrexham)
Fri 29 11:30
OC7.1
Oral Communications 7
Increased and younger alcohol-related hospital admissions in young people with childhood-onset type-1 diabetes: a record-linked longitudinal population study in Wales
UK
Fri 29 11:40
OC7.2
Oral Communications 7
Impact of Continuous Glucose Monitoring on Sleep Quality in Children with Type 1 Diabetes and their Parents: A Pilot Study
Fri 29 11:50
OC7.3
Oral Communications 7
Improving HbA1c Outcomes in Young People of Transition Age with Type 1 Diabetes Using Quality Improvement Methodology
Fri 29 12:00
OC7.4
Oral Communications 7
Monitoring lipid profiles in children and young people with Type 1 Diabetes Mellitus: What should we do with these results?
Liverpool, UK
Fri 29 12:10
OC7.5
Oral Communications 7
Medication adherence during adjunct therapy with statins and ACE inhibitors in adolescents with type 1 diabetes
Fri 29 12:20
OC7.6
Oral Communications 7
Improving referral pathways from primary to secondary care in newly diagnosed Type 1 diabetes
Fri 29 12:30
OC7.7
Oral Communications 7
Paediatric Type 2 diabetes in a single centre in East London in the period 2009-2018
London, UK
Fri 29 12:40
OC7.8
Oral Communications 7
Children with type 1 diabetes on intensive insulin, in deprived areas and younger onset are at risk of being overweight.
Fri 29 12:50
OC7.9
Oral Communications 7
Does having a first degree relative with Type1 Diabetes impact on a child and family’s engagement and glycaemic control?
Expert 0
Plenary 0
Catering and Social 2
Fri 29 11:00
TEA & COFFEE
LOWER HALL
Fri 29 13:00
LUNCH, EXHIBITION & POSTER TOURS
LOWER HALL
Nurse 0
Other 1
Fri 29 14:00
BSPED 2019 AWARDS SESSION
ASSEMBLY ROOM
Chair: Helen Storr (London)
Symposium 2
Fri 29 09:30
Symposium 3
Diabetes Trials
ASSEMBLY ROOM
Chair: Rachel Besser (Oxford)
Fri 29 09:30
S3.1
Symposium 3
Immunotherapy in Type 1 diabetes
Cardiff, Wales
Fri 29 10:00
S3.2
Symposium 3
Role of the environment in the pathogenesis of Type 1 diabetes
Fri 29 10:30
S3.3
Symposium 3
Novel therapies for type 2 diabetes
Fri 29 14:15
Symposium 4
Improving Diabetes Care
ASSEMBLY ROOM
Chair: Fiona Campbell (Leeds)
Fri 29 14:15
S4.1
Symposium 4
How to use QI effectively
Fri 29 14:45
S4.2
Symposium 4
QI in action - the Sheffield Children's Hospital experience
Fri 29 15:15
S4.3
Symposium 4
Lessons from registries
UK
No Session Type 3
Fri 29 08:00
Registration
City Hall Main Entrance
Fri 29 08:15
Sponsored Symposium
Fri 29 15:45
Close of Meeting
ASSEMBLY ROOM
Chair: Justin Warner (Cardiff)

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract